In short, we report the first case of recurrent laryngeal IMT in a 24-year-old patient with a novel THBS1::ALK1 fusion, emphasizing the significance of correlating molecular findings with tumor morphology and recurrent behavior. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.